Latest Reports

The “2026 Retinal Device Market Report” provides a comprehensive, data-driven analysis of the global retinal device market, including market size, growth trends, and the key developments shaping future demand for major product segments such as vitrectomy machines, vitrectomy packs, accessories and allied surgical products, tamponades, retinal medical devices, maintenance and upgrade revenue, and other surgical devices. It also evaluates the current competitive landscape and provides detailed forecasts through 2031, offering clear insight into how the market is expected to evolve over the next five years. 

In addition, the report profiles 19 leading retinal device companies, with in-depth coverage of their product portfolios, strategic positioning, company background, and outlook to provide a clear view of the competitive dynamics driving the market forward. 

The “2026 European Five Ophthalmic Market Report” delivers a comprehensive, data-driven view of Western Europe’s five largest ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—across 11 key submarkets. The report analyzes current market dynamics, identifies the trends shaping demand, and provides clear forecasts through 2031 to support strategic planning and competitive positioning. 

In addition, the report includes detailed disease prevalence forecasts, treatment and procedure volume analysis, emerging technology assessment, and in-depth profiles of leading competitors to provide a complete picture of how these major European markets are evolving and where the strongest opportunities are expected to emerge. 

The "2026 United States Optometry Trends Survey Report" delivers a data-driven view of how optometry practices are structured and evolving—highlighting key trends in clinical care, technology adoption, referral patterns, and growth dynamics. 

Built on extensive primary research and featuring expert commentary from Market Scope, this report explores brand decision drivers and service offerings across medical eye care, contact lenses, dry eye, and myopia management.  

The report also connects optometry to the broader ophthalmic ecosystem, offering unique insight into co-management patterns, cataract and refractive referral behavior, and the factors that drive surgeon selection and premium IOL conversion.  

The “2026 Glaucoma Pharmaceuticals Market Report” provides a data-driven view of the global and regional glaucoma drug markets, highlighting the trends and competitive forces shaping future growth. The report includes forecasts through 2031 across all major therapy classes, including prostaglandins (branded and generic), beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combinations, NO-donating compounds, and Rho-kinase inhibitors. 

In addition, the report examines a robust development pipeline of over 30 drug candidates and profiles 23 leading companies, providing insight into product portfolios, strategic positioning, and future outlook. 

The "2025 India Ophthalmic Market Report" delivers a comprehensive analysis of India’s ophthalmic market, highlighting key trends, competitive dynamics, and factors shaping future growth. The report includes forecasts for disease prevalence, procedure volumes, and technology adoption across diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. 

Profiles of 30 leading competitors provide insight into product portfolios, strategic positioning, and market outlook. 

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.